OTTAWA – A new study in England suggests the Pfizer-BioNTech and Oxford-AstraZeneca vaccines are extremely good at keeping people from ending up in the hospital with COVID-19, even after just one dose.
Public Health England says it looked at the records of 14,000 people with confirmed cases of COVID-19 due to the Delta variant between April 12 and June 4.
It found two doses of either vaccine were more than 90 per cent effective at keeping people out of the hospital.
After one dose, Pfizer was 94 per cent effective against hospitalization, and AstraZeneca’s vaccine was 71 per cent effective.
Novavax COVID-19 vaccine about 90% effective, study shows
Peel top doctor says Delta variant a real risk: ‘Do not hold large gatherings’
Ontario infectious disease specialist Dr. Isaac Bogoch says the study is a ray of hope at a time when “good news is in short supply.”
The UK’s Health and Social Care Secretary Matt Hancock said “This evidence of the effectiveness of two doses against variants shows just how crucial it is to get your second jab.”
“If you have had your first dose but haven’t booked your second yet – please do so. It will help save lives and boost us on the road to recovery,” Hancock said.
Canada’s strategy of getting first doses into the arms of as many people as possible before moving on to second doses has been controversial, leading to health officials urging provincial governments to move quicker.
An earlier study from Public Health England suggests a single dose is far less effective than both doses at preventing symptoms from COVID-19.
Peel’s Medical Officer of Health Dr. Lawrence Loh said last week that while the public health unit’s vaccination rollout has helped limit the spread of the virus, there are growing concerns about the Delta variant and its presence in the community.
Almost two in three Canadians now have one dose of vaccine, but slightly more than one in 10 have both doses.
Canada is pivoting to second doses rapidly, however, with 1.2 million people joining the fully vaccinated group just in the last four days.
The country is poised to receive more than 8 million COVID-19 vaccine doses this week thanks to a massive infusion of shots from Moderna and a revised delivery schedule.
The federal government says the Massachusetts-based pharmaceutical firm will deliver a total of 5.8 million jabs in two separate shipments this week.